Related references
Note: Only part of the references are listed.Impact of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine on Malaria in Ugandan Schoolchildren: A Randomized, Placebo-Controlled Trial
Joaniter I. Nankabirwa et al.
CLINICAL INFECTIOUS DISEASES (2014)
Potential of Artemisinin-Based Combination Therapies to Block Malaria Transmission
Ric N. Price
JOURNAL OF INFECTIOUS DISEASES (2013)
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
Eva Maria Staehli Hodel et al.
MALARIA JOURNAL (2013)
Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies
Cho Naing et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2013)
The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
Jane Achan et al.
PLOS MEDICINE (2013)
Randomized, Double-Blind, Placebo-Controlled Trial of Monthly versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of Malaria
Khin Maung Lwin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Population Pharmacokinetics and Pharmacodynamics of Piperaquine in Children With Uncomplicated Falciparum Malaria
J. Tarning et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
Antoinette K. Tshefu et al.
LANCET (2010)
Short Report: Resistance-mediating Polymorphisms in Plasmodium falciparum Infections in Kinshasa, Democratic Republic of the Congo
Linda Mobula et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Varying efficacy of artesunate plus amodiaquine and artesunate plus sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies
Maryline Bonnet et al.
MALARIA JOURNAL (2009)
dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo
Alisa P. Alker et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria
R. N. Price et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials
Bryan Greenhouse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
Francesco Checchi et al.
MALARIA JOURNAL (2006)
A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria
Y Suputtamongkol et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
